483 Novel Labs d.b.a LUPIN Feb 2017

483 Novel Labs d.b.a LUPIN Feb 2017

Paul Bellamy FDA, Nancy Espinal FDA$119.00 - Available Now

FDA investigators audited the Novel Labs d.b.a LUPIN - Somerset, NJ, United States facility and issued inspectional observations (via FDA 483) on 14 Feb 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 14 Feb 2017
  • Location: Somerset, United States
  • FEI: 3006271438
Add To Cart